-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA PHARMA CO. - REVISED FY2026 FORECAST: NET SALES JPY 48.80 BLN, CORE OPERATING INCOME JPY 22.80 BLN, OPERATING INCOME JPY 15.70 BLN

Reuters·11/04/2026 08:49:08